Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1988 1
1990 1
1991 2
1992 2
1993 1
1994 2
1995 1
1996 2
1997 1
1998 6
2000 6
2001 5
2002 7
2003 5
2004 11
2005 4
2006 5
2007 11
2008 9
2009 15
2010 14
2011 17
2012 17
2013 22
2014 25
2015 19
2016 30
2017 33
2018 32
2019 31
2020 32
2021 36
2022 40
2023 50
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

443 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Brain small vessel disease 3"
Page 1
Cerebral Small Vessel Disease.
Li Q, Yang Y, Reis C, Tao T, Li W, Li X, Zhang JH. Li Q, et al. Cell Transplant. 2018 Dec;27(12):1711-1722. doi: 10.1177/0963689718795148. Epub 2018 Sep 25. Cell Transplant. 2018. PMID: 30251566 Free PMC article. Review.
Cerebral small vessel disease (CSVD) is composed of several diseases affecting the small arteries, arterioles, venules, and capillaries of the brain, and refers to several pathological processes and etiologies. Neuroimaging features of CS …
Cerebral small vessel disease (CSVD) is composed of several diseases affecting the small arteries, arteri …
Cadasil.
Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. Chabriat H, et al. Lancet Neurol. 2009 Jul;8(7):643-53. doi: 10.1016/S1474-4422(09)70127-9. Lancet Neurol. 2009. PMID: 19539236 Review.
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) is the most common heritable cause of stroke and vascular dementia in adults. Clinical and neuroimaging features resemble those of sporadic small-artery disease …
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) is the most common heritable cause of s …
Modifiable Lifestyle Factors and Risk of Stroke: A Mendelian Randomization Analysis.
Harshfield EL, Georgakis MK, Malik R, Dichgans M, Markus HS. Harshfield EL, et al. Stroke. 2021 Mar;52(3):931-936. doi: 10.1161/STROKEAHA.120.031710. Epub 2021 Feb 4. Stroke. 2021. PMID: 33535786 Free PMC article.
RESULTS: Genetically predicted years of education was inversely associated with ischemic, large artery, and small vessel stroke, and intracerebral hemorrhage. Genetically predicted smoking, body mass index, and waist-hip ratio were associated with ischemic and large …
RESULTS: Genetically predicted years of education was inversely associated with ischemic, large artery, and small vessel strok …
Sneddon Syndrome: A Comprehensive Overview.
Samanta D, Cobb S, Arya K. Samanta D, et al. J Stroke Cerebrovasc Dis. 2019 Aug;28(8):2098-2108. doi: 10.1016/j.jstrokecerebrovasdis.2019.05.013. Epub 2019 May 31. J Stroke Cerebrovasc Dis. 2019. PMID: 31160219 Review.
Sneddon syndrome (SS) is an episodic or chronic, slowly progressive disorder and characterized by generalized livedo racemosa (patchy, violaceous, skin discoloration) and recurrent cerebrovascular events. The histopathology of skin and brain is remarkable for a noninflamma …
Sneddon syndrome (SS) is an episodic or chronic, slowly progressive disorder and characterized by generalized livedo racemosa (patchy, viola …
Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease: The Lacunar Intervention Trial-2 (LACI-2) Randomized Clinical Trial.
Wardlaw JM, Woodhouse LJ, Mhlanga II, Oatey K, Heye AK, Bamford J, Cvoro V, Doubal FN, England T, Hassan A, Montgomery A, O'Brien JT, Roffe C, Sprigg N, Werring DJ, Bath PM; Lacunar Intervention Trial-2 (LACI-2) Investigator Group. Wardlaw JM, et al. JAMA Neurol. 2023 Jul 1;80(7):682-692. doi: 10.1001/jamaneurol.2023.1526. JAMA Neurol. 2023. PMID: 37222252 Free PMC article. Clinical Trial.
IMPORTANCE: Cerebral small vessel disease (cSVD) is a common cause of stroke (lacunar stroke), is the most common cause of vascular cognitive impairment, and impairs mobility and mood but has no specific treatment. OBJECTIVE: To test the feasibility, drug tol …
IMPORTANCE: Cerebral small vessel disease (cSVD) is a common cause of stroke (lacunar stroke), is the most common cause …
Genomics of perivascular space burden unravels early mechanisms of cerebral small vessel disease.
Duperron MG, Knol MJ, Le Grand Q, Evans TE, Mishra A, Tsuchida A, Roshchupkin G, Konuma T, Trégouët DA, Romero JR, Frenzel S, Luciano M, Hofer E, Bourgey M, Dueker ND, Delgado P, Hilal S, Tankard RM, Dubost F, Shin J, Saba Y, Armstrong NJ, Bordes C, Bastin ME, Beiser A, Brodaty H, Bülow R, Carrera C, Chen C, Cheng CY, Deary IJ, Gampawar PG, Himali JJ, Jiang J, Kawaguchi T, Li S, Macalli M, Marquis P, Morris Z, Muñoz Maniega S, Miyamoto S, Okawa M, Paradise M, Parva P, Rundek T, Sargurupremraj M, Schilling S, Setoh K, Soukarieh O, Tabara Y, Teumer A, Thalamuthu A, Trollor JN, Valdés Hernández MC, Vernooij MW, Völker U, Wittfeld K, Wong TY, Wright MJ, Zhang J, Zhao W, Zhu YC, Schmidt H, Sachdev PS, Wen W, Yoshida K, Joutel A, Satizabal CL, Sacco RL, Bourque G; CHARGE consortium; Lathrop M, Paus T, Fernandez-Cadenas I, Yang Q, Mazoyer B, Boutinaud P, Okada Y, Grabe HJ, Mather KA, Schmidt R, Joliot M, Ikram MA, Matsuda F, Tzourio C, Wardlaw JM, Seshadri S, Adams HHH, Debette S. Duperron MG, et al. Nat Med. 2023 Apr;29(4):950-962. doi: 10.1038/s41591-023-02268-w. Epub 2023 Apr 17. Nat Med. 2023. PMID: 37069360 Free PMC article.
Perivascular space (PVS) burden is an emerging, poorly understood, magnetic resonance imaging marker of cerebral small vessel disease, a leading cause of stroke and dementia. Genome-wide association studies in up to 40,095 participants (18 population-based co …
Perivascular space (PVS) burden is an emerging, poorly understood, magnetic resonance imaging marker of cerebral small vessel …
A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.
Jodele S, Laskin BL, Dandoy CE, Myers KC, El-Bietar J, Davies SM, Goebel J, Dixon BP. Jodele S, et al. Blood Rev. 2015 May;29(3):191-204. doi: 10.1016/j.blre.2014.11.001. Epub 2014 Nov 28. Blood Rev. 2015. PMID: 25483393 Free PMC article. Review.
Recently, there have been new insights into the incidence, pathophysiology, and management of TA-TMA. Specifically, TA-TMA can manifest as a multi-system disease occurring after various triggers of small vessel endothelial injury, leading to subsequent tissue …
Recently, there have been new insights into the incidence, pathophysiology, and management of TA-TMA. Specifically, TA-TMA can manifest as a …
Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?
Stewart CL, Warner S, Ito K, Raoof M, Wu GX, Kessler J, Kim JY, Fong Y. Stewart CL, et al. Curr Probl Surg. 2018 Sep;55(9):330-379. doi: 10.1067/j.cpsurg.2018.08.004. Epub 2018 Oct 4. Curr Probl Surg. 2018. PMID: 30526930 Free PMC article. Review.
Existing data, however, are largely retrospective. A randomized phase III trial to examine the effect of concurrent lung metastasectomy (PulMiCC trial) is currently underway. ...Whole brain radiation has been used after open surgery and stereotactic ra …
Existing data, however, are largely retrospective. A randomized phase III trial to examine the effect of concurrent lung metas …
Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases (TREAT-SVDs): a multicentre, open-label, randomised, crossover trial.
Kopczak A, Stringer MS, van den Brink H, Kerkhofs D, Blair GW, van Dinther M, Reyes CA, Garcia DJ, Onkenhout L, Wartolowska KA, Thrippleton MJ, Kampaite A, Duering M, Staals J, Lesnik-Oberstein S, Muir KW, Middeke M, Norrving B, Bousser MG, Mansmann U, Rothwell PM, Doubal FN, van Oostenbrugge R, Biessels GJ, Webb AJS, Wardlaw JM, Dichgans M; TREAT-SVDs collaborators. Kopczak A, et al. Lancet Neurol. 2023 Nov;22(11):991-1004. doi: 10.1016/S1474-4422(23)00293-4. Lancet Neurol. 2023. PMID: 37863608 Clinical Trial.
BACKGROUND: Hypertension is the leading risk factor for cerebral small vessel disease. We aimed to determine whether antihypertensive drug classes differentially affect microvascular function in people with small vessel disease. ...Whethe …
BACKGROUND: Hypertension is the leading risk factor for cerebral small vessel disease. We aimed to determine whether an …
Risk factors for cognitive impairment and dementia after stroke: a systematic review and meta-analysis.
Filler J, Georgakis MK, Dichgans M. Filler J, et al. Lancet Healthy Longev. 2024 Jan;5(1):e31-e44. doi: 10.1016/S2666-7568(23)00217-9. Epub 2023 Dec 12. Lancet Healthy Longev. 2024. PMID: 38101426 Free article.
We selected prospective and retrospective cohort studies, post-hoc analyses from randomised controlled trials, and nested case-control studies of patients with acute stroke (ischaemic, haemorrhagic, and transient ischaemic attack), exploring associations between risk facto …
We selected prospective and retrospective cohort studies, post-hoc analyses from randomised controlled trials, and nested case-contro …
443 results